Cargando…

Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer

PURPOSE: There is an urgent need to discover a predictive biomarker to help patients with advanced pancreatic cancer (APC) choose appropriate chemotherapy regimens. This study aimed to determine whether baseline serum amyloid A (SAA) levels were associated with overall survival (OS), progression-fre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Honglu, Yang, Qiuxia, Mao, Yize, Qin, Dailei, Yao, Zehui, Wang, Ruiqi, Qin, Tao, Li, Shengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045337/ https://www.ncbi.nlm.nih.gov/pubmed/36998322 http://dx.doi.org/10.2147/JIR.S404900

Ejemplares similares

Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes
por: Wei, Ran, et al.
Publicado: (2022)

Type 1 T Helper Cell-Based Molecular Subtypes and Signature Are Associated with Clinical Outcome in Pancreatic Ductal Adenocarcinoma
por: Wei, Ran, et al.
Publicado: (2022)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: He, Chaobin, et al.
Publicado: (2019)

Identifying Outcomes of Patients With Advanced Pancreatic Adenocarcinoma and RECIST Stable Disease Using Radiomics Analysis
por: Yang, Qiuxia, et al.
Publicado: (2022)

Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2020)

Retrospective Clinical Study of Advanced Pancreatic Cancer Treated With Chemotherapy and Abdominal Hyperthermia
por: Fan, Yu-Fei, et al.
Publicado: (2017)

SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation
por: Song, Yunda, et al.
Publicado: (2020)

Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer
por: Li, Xujia, et al.
Publicado: (2023)

Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2021)

Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy
por: Yu, Shu-Lin, et al.
Publicado: (2017)

ASO Author Reflections: Prediction of the Chemotherapy Effect on the Prognosis of Locally Advanced Pancreatic Cancer
por: Tanaka, Masayuki, et al.
Publicado: (2022)

Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A
por: Liu, Jin, et al.
Publicado: (2016)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma
por: Wang, Jun-Ye, et al.
Publicado: (2012)

Oxidative stress induces monocyte‐to‐myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma
por: Huang, Xin, et al.
Publicado: (2020)

Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation
por: He, Chaobin, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma
por: He, Chaobin, et al.
Publicado: (2018)

Systemic Chemotherapy in Advanced Pancreatic Cancer
por: Lee, Hee Seung, et al.
Publicado: (2016)

Prognosis Relevance of Serum Cytokines in Pancreatic Cancer
por: Torres, Carolina, et al.
Publicado: (2015)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis
por: He, Chaobin, et al.
Publicado: (2019)

Chemotherapy and prognosis in advanced thymic carcinoma patients
por: Song, Zhengbo, et al.
Publicado: (2015)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma
por: Cheng, Jun, et al.
Publicado: (2022)

Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer
por: Wood, S L, et al.
Publicado: (2010)

Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis
por: Yang, Mu, et al.
Publicado: (2016)

Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis
por: Li, Huan, et al.
Publicado: (2020)

Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
por: Markus, M., et al.
Publicado: (2020)

Induction Chemotherapy with FOLFIRINOX for Locally Advanced Pancreatic Cancer: A Simple Scoring System to Predict Effect and Prognosis
por: Tanaka, Masayuki, et al.
Publicado: (2022)

An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer
por: Xie, Fengxiao, et al.
Publicado: (2022)

Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy
por: He, Chaobin, et al.
Publicado: (2018)

Surgical management of periampullary adenocarcinoma: defining an optimal prognostic lymph node stratification schema
por: He, Chaobin, et al.
Publicado: (2018)

Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma
por: Xia, Qin-Xuan, et al.
Publicado: (2022)

AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer
por: Ma, Zikun, et al.
Publicado: (2023)

Serum amyloid A protein in cancer prognosis: a meta-analysis and systematic review
por: Lai, Yucheng, et al.
Publicado: (2021)

Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19
por: Abbas, Amal A., et al.
Publicado: (2022)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)

RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC
por: Wang, Xiang, et al.
Publicado: (2012)

Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy
por: Du, Juan, et al.
Publicado: (2022)

Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis
por: Tang, Qin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8i03ktah2h04ltb5gd38jg9uli